In hepatocellular carcinoma (HCC), the inhibition of MCT4, either genetically or pharmacologically with VB124, has been shown to suppress tumor growth by enhancing CD8+ T cell infiltration and cytotoxicity. This evidence concerns the gene SLC16A3 and neoplasm.